Published in Gene Therapy Weekly, October 19th, 2006
"The DNA-binding preferences of two oligopeptide amides, (His-Pro-Arg-Lys)(3)NH2 (HR-12) and (Ser-Pro-Arg-Lys)(3)NH2 (SP-12), have been examined by quantitative DNase 1 footprinting studies," wrote C.H. Yang and colleagues, Tunghai University.
"Two different DNA fragments were investigated: a pair of 5'-P-32-labeled duplexes from PBR322 with one or other of the complementary strands labeled and a corresponding pair or 5'-P-32-labeled...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.